Evaluation of L-type amino acid transporter 1 (LAT1) expression by F-18 FBPA PET

Evaluation of LAT1 expression by FBPA PET - FBPA-LAT1

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036478

Enrollment

100

Registered

2019-05-01

Start date

2019-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant tumor

Interventions

PET drug administration

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Targets patients who have been clinically diagnosed with malignancy.

Exclusion criteria

Exclusion criteria: 1. a pregnant and lactating subject or a person who wishes to become pregnant 2. Pediatric patients who need sedation 3. Others who are judged inappropriate

Design outcomes

Primary

Measure	Time frame
The whole body distribution is evaluated using PET-CT, and the uptake in the tumor is quantitatively measured.	—

Countries

Japan

Contacts

Public ContactTadashi Watabe

Osaka University Graduate School of Medicine Department of Nuclear Medicine and Tracer Kinetics

watabe@tracer.med.osaka-u.ac.jp06-6879-3461

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026